Literature DB >> 19127709

Anger experience and anger inhibition in sub-populations of African American and European American older adults and relation to circulatory disease.

Carol Magai1, Michael-David Kerns, Michael Gillespie, Bu Huang.   

Abstract

This study examined ethnic differences in the link between anger experience and anger inhibition and that of circulatory disease (CD). To ascertain the effects of anger inhibition in older persons, health data from groups of African American, African Caribbean, Eastern European and European American adults were collected. Experienced anger and anger inhibition were significant predictors of CD only for the African American group and the relation between experienced anger and CD was mediated by anger inhibition. The data suggest that cultural factors play a role in the development of an anger-inhibitory style and that this trait may pose a serious risk factor for circulatory disease.

Entities:  

Mesh:

Year:  2003        PMID: 19127709     DOI: 10.1177/13591053030084002

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  3 in total

1.  Trait anger, cynical hostility and inflammation in Latinas: variations by anger type?

Authors:  S Shivpuri; L C Gallo; P J Mills; K A Matthews; J P Elder; G A Talavera
Journal:  Brain Behav Immun       Date:  2011-05-01       Impact factor: 7.217

2.  When Anger Remains Unspoken: Anger and Accelerated Epigenetic Aging Among Stress-Exposed Black Americans.

Authors:  Brooke G McKenna; Yara Mekawi; Seyma Katrinli; Sierra Carter; Jennifer S Stevens; Abigail Powers; Alicia K Smith; Vasiliki Michopoulos
Journal:  Psychosom Med       Date:  2021 Nov-Dec 01       Impact factor: 4.312

3.  Factors associated with resident-to-resident elder mistreatment in nursing homes.

Authors:  Karl Pillemer; Stephanie Silver; Mildred Ramirez; Jian Kong; Joseph P Eimicke; Gabriel D Boratgis; Rhoda Meador; Leslie Schultz; Mark S Lachs; Julia Nolte; Emily K Chen; Jeanne A Teresi
Journal:  J Am Geriatr Soc       Date:  2021-12-27       Impact factor: 5.562

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.